Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches
Clinical trial NCT04066023 · COMPLETED
Trial details
- NCT number
- NCT04066023
- Sponsor
- Zosano Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-03
- Primary completion
- 2021-04-14
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.